Blurry Boundaries: Do Epithelial Borderline Lesions of the Breast and Ductal Carcinoma In Situ Have Similar Rates of Subsequent Invasive Cancer?

Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

(2012) D. Craig Allred et al.   JOURNAL OF CLINICAL ONCOLOGY

Borderline Breast Lesions

(2011) Shahla Masood et al.   ADVANCES IN ANATOMIC PATHOLOGY

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

(2011) I. L. Wapnir et al.   JNCI-Journal of the National Cancer Institute

The effect of age in the outcome and treatment of older women with ductal carcinoma in situ

(2010) Alice Ho et al.   BREAST

Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ

(2010) Udo Rudloff et al.   JOURNAL OF CLINICAL ONCOLOGY

Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group

(2009) Lorie L. Hughes et al.   JOURNAL OF CLINICAL ONCOLOGY